170 related articles for article (PubMed ID: 27177758)
1. Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
Li D; Fu J; Du M; Zhang H; Li L; Cen J; Li W; Chen X; Lin Y; Conway EM; Pikarsky E; Wang H; Pan G; Ji Y; Wang HY; Hui L
Hepatology; 2016 Oct; 64(4):1105-20. PubMed ID: 27177758
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65.
Liu ZC; Ning F; Wang HF; Chen DY; Cai YN; Sheng HY; Lash GE; Liu L; Du J
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2568-2582. PubMed ID: 28844984
[TBL] [Abstract][Full Text] [Related]
3. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
4. B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury.
Faggioli F; Palagano E; Di Tommaso L; Donadon M; Marrella V; Recordati C; Mantero S; Villa A; Vezzoni P; Cassani B
Hepatology; 2018 May; 67(5):1970-1985. PubMed ID: 29105104
[TBL] [Abstract][Full Text] [Related]
5. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage.
Park SS; Jwa E; Shin SH; Ju EJ; Park I; Pak JH; Hwang JJ; Cho DH; Kim BM; Kim SB; Lee JS; Song SY; Jeong SY; Choi EK
Int J Biochem Cell Biol; 2017 Feb; 83():47-55. PubMed ID: 27923747
[TBL] [Abstract][Full Text] [Related]
6. Survivin in survival of hepatocellular carcinoma.
Su C
Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
11. TNFα induces Ca
Zhu J; Jin M; Wang J; Zhang H; Wu Y; Li D; Ji X; Yang H; Yin C; Ren T; Xing J
J Exp Clin Cancer Res; 2018 Mar; 37(1):43. PubMed ID: 29506556
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
13. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus encoding XAF-1 and TNF‑α in the same open reading frame efficiently inhibits hepatocellular cancer cells.
Li K; Li X; Wu Z; Zheng L; Cui Y; Wang J; Huang Y; Yan Z
Mol Med Rep; 2016 Jun; 13(6):5169-76. PubMed ID: 27121136
[TBL] [Abstract][Full Text] [Related]
15. Survivin promotes cell proliferation in human hepatocellular carcinoma.
Ito T; Shiraki K; Sugimoto K; Yamanaka T; Fujikawa K; Ito M; Takase K; Moriyama M; Kawano H; Hayashida M; Nakano T; Suzuki A
Hepatology; 2000 May; 31(5):1080-5. PubMed ID: 10796883
[TBL] [Abstract][Full Text] [Related]
16. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.
Bollard J; Miguela V; Ruiz de Galarreta M; Venkatesh A; Bian CB; Roberto MP; Tovar V; Sia D; Molina-Sánchez P; Nguyen CB; Nakagawa S; Llovet JM; Hoshida Y; Lujambio A
Gut; 2017 Jul; 66(7):1286-1296. PubMed ID: 27849562
[TBL] [Abstract][Full Text] [Related]
17. DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
Borghesan M; Fusilli C; Rappa F; Panebianco C; Rizzo G; Oben JA; Mazzoccoli G; Faulkes C; Pata I; Agodi A; Rezaee F; Minogue S; Warren A; Peterson A; Sedivy JM; Douet J; Buschbeck M; Cappello F; Mazza T; Pazienza V; Vinciguerra M
Cancer Res; 2016 Feb; 76(3):594-606. PubMed ID: 26772755
[TBL] [Abstract][Full Text] [Related]
18. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells.
Liese J; Abhari BA; Fulda S
Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA.
Shen J; Sun H; Meng Q; Yin Q; Zhang Z; Yu H; Li Y
Mol Pharm; 2014 Oct; 11(10):3342-51. PubMed ID: 24495194
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2.
Huang BP; Lin CS; Wang CJ; Kao SH
Int J Med Sci; 2017; 14(3):284-293. PubMed ID: 28367089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
